The Vasopressin Loading for Refractory septic shock (VALOR) study: a prospective observational study

被引:6
作者
Nakamura, Kensuke [1 ,2 ]
Nakano, Hidehiko [2 ]
Ikechi, Daisuke [2 ]
Mochizuki, Masaki [2 ]
Takahashi, Yuji [2 ]
Koyama, Yasuaki [2 ]
Hashimoto, Hideki [2 ]
Abe, Toshikazu [3 ,4 ]
Hayakawa, Mineji [5 ]
Yamakawa, Kazuma [6 ]
机构
[1] Yokohama City Univ Med, Dept Crit Care Med, 3-9 Fukuura, Kanazawa-ku, Yokohama, Kanagawa 2360004, Japan
[2] Hitachi Gen Hosp, Dept Emergency & Crit Care Med, 2-1-1, Jonan-cho, Hitachi, Ibaraki 3170077, Japan
[3] Tsukuba Mem Hosp, Dept Emergency & Crit Care Med, 1187-299, Kaname, Tsukuba, Ibaraki 3002622, Japan
[4] Univ Tsukuba, Fac Med, Dept Hlth Serv Res, 1-1-1, Tennodai, Tsukuba, Ibaraki 3058575, Japan
[5] Hokkaido Univ Hosp, Dept Emergency Med, Kita 14-jo Nishi 5-chome, Kita-ku, Sapporo, Hokkaido 0608648, Japan
[6] Osaka Med Coll Hosp, Dept Emergency Med, 2-7 Daigakumachi, Takatsuki, Osaka 5698686, Japan
关键词
Critical care; Septic shock; Sepsis; Vasopressin; Loading; Bolus; INFUSION; NOREPINEPHRINE; TERLIPRESSIN; HORMONE;
D O I
10.1186/s13054-023-04583-7
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
BackgroundVasopressin is a second-line vasoactive agent for refractory septic shock. Vasopressin loading is not generally performed because of the lack of evidence for its effects and safety. However, based on our previous findings, we hypothesized it can predict the responsibility to vasopressin infusion with safety, and prospectively examined it in the present study.MethodsVasopressin loading was performed via the intravenous administration of a bolus of 1 U, followed by its continuous infusion at 1U/h in patients with septic shock treated with & GE; 0.2 & mu;g/kg/min noradrenaline. An arterial pressure wave analysis was conducted, and endocrinological tests were performed immediately prior to vasopressin loading. We classified patients into responders/non-responders based on mean arterial pressure (MAP) changes after vasopressin loading. Based on our previous findings, the lower tertile of MAP changes was selected as the cut-off. The change in the catecholamine index (CAI) after 6 h was assigned as the primary outcome. Digital ischemia, mesenteric ischemia, and myocardial ischemia during the admission period were prospectively and systematically recorded as adverse events.ResultsNinety-two patients were registered during the study period and examined. Sixty-two patients with a MAP change > 22 mmHg were assigned as responders and the others as non-responders. Blood adrenocorticotropic hormone levels were significantly higher in non-responders. Stroke volume variations were higher in responders before loading, while stroke volume and dP/dt(max) were higher in responders after loading. Median CAI changes were - 10 in responders and 0 in non-responders, which was significantly lower in the former (p < 0.0001). AUROC of MAP change with vasopressin loading to predict CAI change < 0 after continuous infusion was 0.843 with sensitivity of 0.92 and specificity of 0.77. Ischemia events were observed in 5 cases (5.4%).ConclusionsVasopressin loading may be safely introduced for septic shock. Vasopressin loading may be used to predict responses to its continuous infusion and select appropriate strategies to increase blood pressure.
引用
收藏
页数:9
相关论文
共 28 条
  • [1] Vasopressin: Mechanisms of action on the vasculature in health and in septic shock
    Barrett, Lucinda K.
    Singer, Mervyn
    Clapp, Lucie H.
    [J]. CRITICAL CARE MEDICINE, 2007, 35 (01) : 33 - 40
  • [2] Norepinephrine kinetics and dynamics in septic shock and trauma patients
    Beloeil, H
    Mazoit, JX
    Benhamou, D
    Duranteau, J
    [J]. BRITISH JOURNAL OF ANAESTHESIA, 2005, 95 (06) : 782 - 788
  • [3] Bracco D, 2001, INTENS CARE MED, V27, pS138
  • [4] PHYSIOLOGIC STUDIES OF ANTIDIURETIC HORMONE BY ITS DIRECT MEASUREMENT IN HUMAN PLASMA
    CZACZKES, JW
    KLEEMAN, CR
    KOENIG, M
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1964, 43 (08) : 1625 - &
  • [5] Ischemic skin lesions as a complication of continuous vasopressin infusion in catecholamine-resistant vasodilatory shock:: Incidence and risk factors
    Dünser, MW
    Mayr, AJ
    Tür, A
    Pajk, W
    Barbara, F
    Knotzer, H
    Ulmer, H
    Hasibeder, WR
    [J]. CRITICAL CARE MEDICINE, 2003, 31 (05) : 1394 - 1398
  • [6] RENAL MICROVASCULAR EFFECTS OF VASOPRESSIN AND VASOPRESSIN ANTAGONISTS
    EDWARDS, RM
    TRIZNA, W
    KINTER, LB
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY, 1989, 256 (02): : F274 - F278
  • [7] Evans L, 2021, INTENS CARE MED, V47, P1181, DOI [10.1007/s00134-021-06506-y, 10.1097/CCM.0000000000005337]
  • [8] Effect of Early Vasopressin vs Norepinephrine on Kidney Failure in Patients With Septic Shock The VANISH Randomized Clinical Trial
    Gordon, Anthony C.
    Mason, Alexina J.
    Thirunavukkarasu, Neeraja
    Perkins, Gavin D.
    Cecconi, Maurizio
    Cepkova, Magda
    Pogson, David G.
    Aya, Hollmann D.
    Anjum, Aisha
    Frazier, Gregory J.
    Santhakumaran, Shalini
    Ashby, Deborah
    Brett, Stephen J.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2016, 316 (05): : 509 - 518
  • [9] SYMMETRICAL PERIPHERAL GANGRENE - ASSOCIATION WITH NORADRENALINE ADMINISTRATION
    HAYES, MA
    YAU, EHS
    HINDS, CJ
    WATSON, JD
    [J]. INTENSIVE CARE MEDICINE, 1992, 18 (07) : 433 - 436
  • [10] Physiology of vasopressin relevant to management of septic shock
    Holmes, CL
    Patel, BM
    Russell, JA
    Walley, KR
    [J]. CHEST, 2001, 120 (03) : 989 - 1002